Eupraxia Pharmaceuticals Inc【EPRX】株式ニュース | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Eupraxia Pharmaceuticals Inc (EPRX)
Eupraxia Pharmaceuticals Inc (EPRX) ニュース

Eupraxia Pharmaceuticals Inc (EPRX)

3.60

0.34

(10.43%)

終了 11月21日 6:00AM

3.60

0.00

( 0.00% )

プレマーケット: 7:13PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI...

Form D - Notice of Exempt Offering of Securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024...

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024 PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

WooptdooU

WooptdooU 1分前

Did OLED stop without GRIFTER lebby? No, it thrived...CORPORATE WELFARIST, GRIFTER lebby needs to go. Let's see if the pic industry likes a guy likes him after all...

WebSlinger

WebSlinger 2分前

>

That is a completely false narrative.

The last time, SMCI didn't report financials for about a year (between Nov 2017 and Aug 2018) and they had received 7 Notices of Delisting before they

misterfishman

misterfishman 3分前

I say forget about this one and come back in a year go trade other plays while this one grows ,if one keep watching this everyday then the impatience and frustration will only drive one nuts.

blanka

lol you been saying that since $30k

JOoa0ky

JOoa0ky 4分前

They'd have to sell all their shares prior to accepting the position.
Hence why John Paulson -declined-

eagpup

I hope nexboard does have great success? However, I have heard these great stories of the next best things that will disrupt and be successful. I am at the prove it to me stage. I would like to be part of a penny stock that beats the odds. But the reality is, few penny stocks make it. Put up or I am

Iggy_Bot

Iggy_Bot 5分前

Just a “Elderly Man with a Poor Memory”

PonkenPlonken

PonkenPlonken 6分前

Does anyone in here believe SAVA is a scam? Ph3 results coming soon and they already went above and beyond to cheat on the ph1 and ph2 data set. The ph3 data set will be impossible to skew I believe.

GBR

In yesterdays Needham conference,

RS said they had 485 employees

misterfishman

misterfishman 7分前

Of course. Rome conquered and robbed everybody at the time.

Truth_is_a_tool

Truth_is_a_tool 7分前

Or not lol . Oh well. Maybe next week 🤷‍♂️

Thomas@yahoo

Thomas@yahoo 8分前

Welcome Back and Now Our 47th PRESIDENT OF THE UNITED STATES DONALD J. TRUMP
https://www.marijuanamoment.net/dr-oz-could-elevate-medical-marijuana-support-as-trumps-medicare-and-medicaid-director/

https://www.marijuanamoment.net/fda-approves-long-awaited-clinical-trial-of-smoke

IB_

As we both know "nasrat said" is not even close to a guarantee !!!!!!!!!!!

I only go by what "nasrat did" .....

How many ANDA's has "nasrat said" would be filed in 2024 ???????????

How many were actually filed ???????????

Hey Thanks A Lot

GBR

Well my take on that is much of the underlying tech with aiWARE is from AWS.

I think aiWARE is basically a patented framework. Using open source tech and AWS tech, but applying it to their own proprietary patented framework or AI operating system as they call it.

Eve

Konaploinks

Konaploinks 8分前

Up early. Fell asleep early. Watching Fox News. Charles Payne just mentioned he is watching quantum computing to what’s his name? Anyway what his name says oh. Quantum computing? Then it switches to end of segment on to Carly shimkus ? And she says. Quantum computing? I’m going to have to google tha

mrMadMax

mrMadMax 8分前

🤡We will give a free tricycle to these two clowns🤡, Jimr1717 and Pickme2, so you can go around and scare "people" with your nonsense. However, nobody will believe this absurdity BS —no one at all. Poor fools; your insinuations are just as ridiculous as you are.🤡 Instead of bo

KVM

Somebody should just scoop them up for $5 per share and end everyone's misery.

cashclan

cashclan 8分前

Same reason

You cut and past nothing but left wing opinion articles ...I am just trying to keep up with the Jones.

There is absolutely zero difference other than my posting shed a little more truth.

SHEEPWOLF

SHEEPWOLF 9分前

$ILLR GREEN 12 OF LAST 18 SESSIONS
•STRONG UPTREND INTACT
•ALL DIPS GET EATEN
https://investorshub.advfn.com/uimage/uploads/2024/11/21/buiqeimageedit_36_6627094413.jpg

SHEEPWOLF

SHEEPWOLF 9分前

$ILLR GREEN 12 OF LAST 18 SESSIONS
•STRONG UPTREND INTACT
•ALL DIPS GET EATEN
https://investorshub.advfn.com/uimage/uploads/2024/11/21/buiqeimageedit_36_6627094413.jpg

quickensupportnumber12

quickensupportnumber12 10分前

Quicken users, are you stuck with software or account issues? Don’t worry—call +1-888-848-2409 for immediate support. Whether you’re dealing with login troubles, password recovery, or troubleshooting errors, their expert team is available to assist you. Support hours are 5 am to 5 pm PST, seven days

toohot

toohot 10分前

Outstanding post, edbi46! Very well stated for our beloved BIEL. I’ve always preached that patience is the key. And I truly believe that patience is still needed for our beloved BIEL. Just a little longer.

BUY $BIEL$

KVM

Exactly how do they have the manpower yet they have over 500 employees with a revenue per employee of over 200k. They need at least 225 mil of revs to break even. Their push backed 2026 breakeven projection isn't correct even based on their 30% growth. But again they have never got any #s right.

Polymer Paul

Polymer Paul 13分前

I think it's pretty obvious... Timelines should have been met... But lebby botched the negotiations being too demanding. And in the end other companies opted for other solutions which probably workout cheaper when you take lebby and marcelli out of the pay packet. This scenario is very very believab

Eupraxia Pharmaceuticals

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約